Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells
Marine Drugs · 2024
DOI: 10.3390/md22080357 ↗Kurz gefasst
Fachartikel in der Zeitschrift Marine Drugs, 2024. Verfasst von Genshi Zhao und 13 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical College, Guangxi Medical University, Nanning 530021, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Ferroptosis, Colorectal Neoplasms, Zebrafish. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Guangxi Key Research and Development Program, Natural Science Foundation of Guangxi Zhuang Autonomous Region.
Abstract (Originalsprache)
Ferroptosis has emerged as a potential mechanism for enhancing the efficacy of chemotherapy in cancer treatment. By suppressing nuclear factor erythroid 2-related factor 2 (Nrf2), cancer cells may lose their ability to counteract the oxidative stress induced by chemotherapy, thereby becoming more susceptible to ferroptosis. In this study, we investigate the potential of penexanthone A (PXA), a xanthone dimer component derived from the endophytic fungus Diaporthe goulteri, obtained from mangrove plant Acanthus ilicifolius, to enhance the therapeutic effect of cisplatin (CDDP) on colorectal cancer (CRC) by inhibiting Nrf2. The present study reported that PXA significantly improved the ability of CDDP to inhibit the activity of and induce apoptosis in CRC cells. Moreover, PXA was found to increase the level of oxidative stress and DNA damage caused by CDDP. In addition, the overexpression of Nrf2 reversed the DNA damage and ferroptosis induced by the combination of PXA and CDDP. In vivo experiments using zebrafish xenograft models demonstrated that PXA enhanced the therapeutic effect of CDDP on CRC. These studies suggest that PXA enhanced the sensitivity of CRC to CDDP and induce ferroptosis by targeting Nrf2 inhibition, indicating that PXA might serve as a novel anticancer drug in combination chemotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- First Clinical Medical College, Guangxi Medical University, Nanning 530021, China.
- Pharmaceutical College, Guangxi Medical University, Nanning 530021, China.
- Guangxi Key Laboratory for Bioactive Molecules Research and Evaluation, Nanning 530021, China.
ORCID-Profile: Hongwei Guo, Dan Zhu
Förderung
- National Natural Science Foundation of China
- Guangxi Key Research and Development Program
- Natural Science Foundation of Guangxi Zhuang Autonomous Region
- Innovative Team for Traditional Chinese Medicinal Materials Quality of Guangxi
- Advanced Innovation Teams and Xinghu Scholars Program of Guangxi Medical University and Guangxi Medical University Student Innovation and Entrepreneurship Trai…
Zitieren
APA
Zhao, G., Liu, Y., Wei, X., Yang, C., Lu, J., Yan, S., Ma, X., Cheng, X., You, Z., Ding, Y., Guo, H., Su, Z., Xing, S., & Zhu, D. (2024). Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells. Marine Drugs. https://doi.org/10.3390/md22080357
Vancouver
Zhao G, Liu Y, Wei X, Yang C, Lu J, Yan S, et al. Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells. Marine Drugs. 2024. doi:10.3390/md22080357
BibTeX
@article{Zhao2024,
author = {Zhao, Genshi and Liu, Yanying and Wei, Xia and Yang, Chunxia and Lu, Junfei and Yan, Shihuan and Ma, Xiaolin and Cheng, Xue and You, Zhengliang and Ding, Yue and Guo, Hongwei and Su, Zhiheng and Xing, Shangping and Zhu, Dan},
title = {Identification of Penexanthone A as a Novel Chemosensitizer to Induce Ferroptosis by Targeting Nrf2 in Human Colorectal Cancer Cells},
journal = {Marine Drugs},
year = {2024},
doi = {10.3390/md22080357}
}
EUVIMED